Trial intelligence / Profile preview

NAC for Noise-induced Hearing Loss

NCT00552786Phase 2Completed

Sponsor
National Taiwan University Hospital
Start
Nov 2007
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acetylcysteine in noise-induced hearing loss (NIHL), sponsored by National Taiwan University Hospital. Started Nov 2007; status: completed.

02

Drugs

acetylcysteine
03

Conditions

noise-induced hearing loss (NIHL)

Beyond the preview

Go deeper on NCT00552786.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00552786.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call